SCHEMBL20848692

SCHEMBL20848692

N#Cc1ccc(-c2ccc(-c3ccccc3)cc2F)c(F)c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACLY P53396 2/20 0.50
KIF11 P52732 1/20 0.50
CYP11B1 P15538 3/20 0.49
CYP11B2 P19099 3/20 0.49
PDK2 Q15119 2/20 0.44
GABRG2 P18507 4/20 0.44
GABRB3 P28472 4/20 0.44
GABRA5 P31644 4/20 0.44
GABRA3 P34903 4/20 0.44
GABRA1 P14867 1/20 0.43
EGLN2 Q96KS0 2/20 0.43
PTPN5 P54829 1/20 0.42
CHEK1 O14757 1/20 0.41
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
CYP19A1 P11511 1/20 0.41
PGR P06401 1/20 0.40
ALOX5AP P20292 1/20 0.40
FEN1 P39748 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20848438 0.92 ACLY (0.50) ACLYKIF11CYP11B1CYP11B2PDK2
SCHEMBL20848429 0.92 ACLY (0.50) ACLYKIF11CYP11B1CYP11B2PDK2
SCHEMBL18499494 0.90 KIF11 (0.54) ACLYKIF11CYP11B1CYP11B2PDK2
SCHEMBL19308493 0.90 KIF11 (0.54) ACLYKIF11CYP11B1CYP11B2PDK2
SCHEMBL2815929 0.87 EGLN2 (0.46) ACLYCYP11B1CYP11B2GABRG2GABRB3
SCHEMBL20793914 0.86 ABCG2 (0.47) CYP11B1CYP11B2EGLN2PDE3BPDE3A
SCHEMBL20867230 0.84 ABCG2 (0.48) CYP11B1CYP11B2GABRG2GABRB3GABRA5
SCHEMBL20663902 0.83 MEN1 (0.48) CYP11B1CYP11B2PDK2ALOX5APFEN1
SCHEMBL20848945 0.83 ACLY (0.53) ACLYKIF11CYP11B1CYP11B2PDK2
SCHEMBL20867242 0.82 ABCG2 (0.50) CYP11B1CYP11B2GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10978646-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2021-04-13 US disclosed
US-20190097141-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2019-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10978646-B2 Organic molecules for use in optoelectronic devices OCIAD2, OCIAD1, POU2F1 ACLY 1298/4885KIF11 419/4885CYP11B1 2072/4885
US-20190097141-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OCIAD2, OCIAD1, POU2F1 ACLY 1298/4885KIF11 419/4885CYP11B1 2072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.